Next Article in Journal
Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas
Next Article in Special Issue
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers
Previous Article in Journal
A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment
Previous Article in Special Issue
Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review
 
 
Article

Article Versions Notes

Cancers 2021, 13(18), 4649; https://doi.org/10.3390/cancers13184649
Action Date Notes Link
article pdf uploaded. 16 September 2021 13:37 CEST Version of Record https://www.mdpi.com/2072-6694/13/18/4649/pdf-vor
article pdf uploaded. 17 September 2021 09:21 CEST Updated version of record https://www.mdpi.com/2072-6694/13/18/4649/pdf-vor
article xml file uploaded 18 September 2021 10:54 CEST Original file -
article xml uploaded. 18 September 2021 10:54 CEST Update -
article pdf uploaded. 18 September 2021 10:55 CEST Updated version of record https://www.mdpi.com/2072-6694/13/18/4649/pdf-vor
article supplementary file uploaded. 18 September 2021 10:55 CEST - https://www.mdpi.com/2072-6694/13/18/4649#supplementary
article html file updated 18 September 2021 10:56 CEST Original file -
article xml file uploaded 24 September 2021 15:04 CEST Update -
article xml uploaded. 24 September 2021 15:04 CEST Update https://www.mdpi.com/2072-6694/13/18/4649/xml
article pdf uploaded. 24 September 2021 15:04 CEST Updated version of record https://www.mdpi.com/2072-6694/13/18/4649/pdf
article html file updated 24 September 2021 15:06 CEST Update -
article html file updated 30 July 2022 06:08 CEST Update https://www.mdpi.com/2072-6694/13/18/4649/html
Back to TopTop